Stem Cells Spin S.A. (WSE:SCS)

Market Cap	16.12M +130.8%
Revenue (ttm)	65.18K +12.5%
Net Income	-551.71K
EPS	-0.01
Shares Out	41.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,913
Open	0.4500
Previous Close	0.3800
Day's Range	0.3800 - 0.4580
52-Week Range	0.1650 - 0.5150
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wrocław, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2009
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SCS

Financial Performance

In 2025, Stem Cells Spin's revenue was 65,736, an increase of 21.11% compared to the previous year's 54,280. Losses were -517,987, -0.44% less than in 2024.